Qingxia Fu, Jiancheng Wang, & Hong Liu. (2020). Chemo-immune synergetic therapy of esophageal carcinoma: Trastuzumab modified, cisplatin and fluorouracil co-delivered lipid-polymer hybrid nanoparticles. Taylor & Francis Group.
Chicago Style (17th ed.) CitationQingxia Fu, Jiancheng Wang, and Hong Liu. Chemo-immune Synergetic Therapy of Esophageal Carcinoma: Trastuzumab Modified, Cisplatin and Fluorouracil Co-delivered Lipid-polymer Hybrid Nanoparticles. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationQingxia Fu, et al. Chemo-immune Synergetic Therapy of Esophageal Carcinoma: Trastuzumab Modified, Cisplatin and Fluorouracil Co-delivered Lipid-polymer Hybrid Nanoparticles. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.